Enlightenment of Canada’s Drug Special Access Program on China’s Compassionate Use System

OBJECTIVE To provide foreign experience for the improvement of China's compassionate use system under the background that there is no specific medicine for patients with COVID-19. METHODS Studied the specific content of Canada's special access program through literature research methods and so on. RESULTS Canada has a relatively perfect system, which was worthy of our country's reference. CONCLUSION According to the specific national conditions of our country, compassionate use system should be improved from three dimensions:doctor, government and drug manufacturer.